Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2005
10/18/2005US6955883 Life sciences business systems and methods
10/18/2005US6955812 Health food and preparation having an anti-obesity effect
10/18/2005US6955810 Method for the treatment of inflammatory disorders
10/18/2005CA2369093C Anticonvulsant derivatives useful in lowering lipids
10/18/2005CA2340138C 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/18/2005CA2335451C Process and product for promoting weight loss in overweight dogs
10/18/2005CA2334702C Pharmaceutical compositions and uses for androst-5-ene-3.beta.,17.beta.-diol
10/18/2005CA2132544C Angiotensin ii antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy
10/13/2005WO2005095604A1 Rf rp transgenic animal
10/13/2005WO2005095452A1 Calcium ion leakage inhibitors
10/13/2005WO2005095443A1 Drug delivery system using peptide modification
10/13/2005WO2005095438A1 Saponins, the preparation and the use of the same
10/13/2005WO2005095436A1 Glycoside having 4-methylergost-7-en-3-ol skeleton and drug for ameliorating hyperglycemia
10/13/2005WO2005095429A1 Phenol derivative, medicinal composition containing the same, and medicinal use thereof
10/13/2005WO2005095414A1 Adiponectin increasing agent
10/13/2005WO2005095381A1 Dipeptidyl peptidase inhibitors
10/13/2005WO2005095373A1 Naphthalene derivative, medicinal composition containing the same, and medicinal use thereof
10/13/2005WO2005095372A1 Naphthalene derivative, medicinal composition containing the same, and medicinal use thereof
10/13/2005WO2005095364A1 Phenoxyacetic acid derivative and medicine containing the same
10/13/2005WO2005095363A1 Bicyclic compound and medicine containing the same
10/13/2005WO2005095338A1 Alkoxyphenylpropanoic acid derivatives
10/13/2005WO2005095331A1 Agent for binding sugar chain to peptide
10/13/2005WO2005094885A1 Preventive and/or therapeutic agent for disease accompanied by chronic muscle/skeleton pain
10/13/2005WO2005094881A1 Antibody drug
10/13/2005WO2005094866A1 Adiponectin expression inducer and utilization of the same
10/13/2005WO2005094858A1 Antidiabetic composition
10/13/2005WO2005094842A1 Vitamin b12-containing compositions and methods of use
10/13/2005WO2005094838A1 Drugs, foods and drinks for ameliorating hyperglycemia
10/13/2005WO2005094812A1 Nateglinide-containing preparation
10/13/2005WO2005046689A3 Use of a pyrazole derivative for preparing medicaments for the prevention and the treatment of dyslipidemia and illnesses associated with dyslipidemia and/or obesity
10/13/2005WO2005026741B1 Non-peptide agonists and antagonists of adrenomedullin and gastrin releasing peptide
10/13/2005US20050229260 Compound screens relating to insulin deficiency or insulin resistance
10/13/2005US20050228170 B7-like molecules and uses thereof
10/13/2005US20050228050 Novel stable crystals of substituted phenylpropionic acid derivative and process for producing the same
10/13/2005US20050228042 Statin-like compounds
10/13/2005US20050228036 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
10/13/2005US20050228011 use of carboxy-functional benzofurans or benzothiophenes to treat tumor growth, metastasis, osteoporosis, restenosis, inflammation, macular degeneration, diabetic retinopathy, rheumatoid arthritis, and sickle cell anemia; greater bioavailability or fewer side-effects
10/13/2005US20050228005 Protein kinase inhibitors and uses thereof
10/13/2005US20050228001 Methods and compositions for treating platelet-related disorders
10/13/2005US20050227997 Selective inhibition of aggrecanase in osteoarthritis treatment
10/13/2005US20050227991 Containing a piperazine ring, e.g., N'-(4-{4-[5-(1,2-dithiolan-3-yl)pentanoyl]-1-piperazinyl)phenyl)-2-thiophenecarboximidamide and intermediates for preparing them; useful for inhibiting NO synthase and regenerating antioxidants
10/13/2005US20050227988 compounds capable of inhibiting, modulating and/or regulating signal transduction of both receptor-type and non-receptor type tyrosine kinases; gliomas, meningomas, cancers, Hodgkin's disease, retinal vascularization; core structure that comprises a benzazocine moiety
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227974 Aminoalkyl-substituted aryl compounds and their use as sodium channel blockers
10/13/2005US20050227973 Human adam-10 inhibitors
10/13/2005US20050227972 treating disorders of the cardiovascular system; adenosine receptor agonists/antagonists
10/13/2005US20050227957 Therapy for oxidation stresses; complex of drug and enzyme mimetics; lipophilic cation moiety covalently bonded to glutathione peroxidase mimetic moiety is selected from the group consisting of: benzisoselenazolones, diaryl diselenides and diaryl selenides
10/13/2005US20050227954 Hypoglycemic agent
10/13/2005US20050227951 Verification of translation
10/13/2005US20050227948 Hif hydroxylase inhibitors
10/13/2005US20050227353 Methods of inducing differentiation of stem cells
10/13/2005US20050227280 Proteases
10/13/2005US20050226941 Composition for controlling excessive calorie intake-induced disorder, food product for controlling excessive calorie intake-induced disorder, skin preparation for external use for controlling
10/13/2005US20050226877 administration of a function blocking antibody which is capable of binding an epitope of VLA-1; arthritis
10/13/2005US20050226849 Compositions and methods of using capsid protein from Flaviviruses and Pestiviruses
10/13/2005US20050226813 Labelled somatostatin analogs backbone cyclized through metal complexation
10/13/2005DE102004012921A1 New 7-butynyl-8-(3-amino-1-piperidinyl)xanthine derivatives useful as dipeptidyl peptidase IV inhibitors, e.g. for treating diabetes, arthritis, obesity and osteoporosis
10/13/2005CA2794424A1 Multi-vitamin and mineral nutritional supplements
10/13/2005CA2563117A1 Treatment of type 1 diabetes with inhibitors of macrophage migration inhibitory factor
10/13/2005CA2562944A1 Adiponectin enhancer
10/13/2005CA2562700A1 Novel pharmaceutical compositions
10/13/2005CA2561732A1 Antibody drug
10/13/2005CA2561383A1 Prophylactic and/or therapeutic agents for chronic musculoskeletal pain
10/13/2005CA2560011A1 Cospeptin, cosmedin and their uses
10/13/2005CA2560005A1 Phenol derivative, medicinal composition containing the same, and medicinal use thereof
10/13/2005CA2558915A1 Pyrimidine derivatives and methods of treatment related to the use thereof
10/12/2005EP1584925A1 Novel screening method
10/12/2005EP1583762A1 Pyrrolyl-thiazoles and their use as cb 1 receptor inverse agonists
10/12/2005EP1583760A2 Substituted heterocyclic compounds
10/12/2005EP1583758A1 Derivative of 5-(4-bromophenyl)-1-(2,4-dichlorophenly)-4-ethyl-n-(piperidine-1-yl)-1h-pyrazol-3-carboxamide, the preparation and therapeutic use thereof
10/12/2005EP1583754A1 Thiophene derivative ppar modulators
10/12/2005EP1583751A1 Substituted heterocyclic compounds useful in the treatment of cardiovascular diseases
10/12/2005EP1583746A1 A pyrazole derivative as ppar modulator
10/12/2005EP1583744A2 Substituted benzylamine derivatives and methods of use
10/12/2005EP1583743A1 Indole-phenylsulfonamide derivatives used as ppar-delta activating compounds
10/12/2005EP1583742A1 Novel cb 1 receptour inverse agonists
10/12/2005EP1583741A1 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists
10/12/2005EP1583738A1 Indenoncarboxylic acids derivatives and their use for the treatment of and preventing diabetes and dyslipidaemia
10/12/2005EP1583547A1 Anti-obesity ingretients from medicinal plants and their composittion
10/12/2005EP1583532A1 Quinoline derivatives as glucokinase ligands
10/12/2005EP1583529A2 Amino acid phenoxy ethers
10/12/2005EP1494546B1 Method for the production of potato juice products by means of food technology
10/12/2005EP1414819B1 THERAPEUTIC 1H-PYRIDO[4,3-b]INDOLES
10/12/2005EP1370568B1 Chemical compounds
10/12/2005EP1272666B1 A functional assay of high-density lipoprotein
10/12/2005EP1224173B1 Pyrazole derivatives as cannabinoid receptor antagonists
10/12/2005EP1202986B1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
10/12/2005EP1202964B1 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands
10/12/2005EP1194421B1 Selective npy (y5) antagonists
10/12/2005EP1169322B1 Pyridoxal analogues for the treatment of disorders caused by a deficiency in vitamin b6
10/12/2005EP1162890B1 A method of preventing parturient hypocalcemia in animals and compositions used therein
10/12/2005EP1150982B1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkB-alpha
10/12/2005EP1143949B1 19-nor-vitamin d3 compounds with calcemic activity
10/12/2005EP1140033B1 Improved controlled release compositions
10/12/2005EP1140027B1 Dosage forms comprising porous particles
10/12/2005EP1100787B1 Lipid-lowering quinazoline derivative
10/12/2005EP0946170B1 Diclofenac for the treatment of vasculopathies
10/12/2005EP0814842B1 Method for treating amyloidosis
10/12/2005CN1681823A Furoisoquinoline derivative and its application
10/12/2005CN1681818A Azaindole kinase inhibitors
1 ... 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 ... 1298